fda glp-1 safety alert october 2025 US removes suicidal thoughts warning from weight-loss drugs Semaglutide Safety Alerts, Recalls &

Vining et al

E 81 , 061920 (2010) H

Saxenda (liraglutide) injection 3 mg is an injectable prescription medicine used for adults with obesity or overweight (excess weight) who also have weight-related medical problems, and children aged 12-17 years with a body weight above 132 pounds (60 kg) and obesity to help them lose weight and keep the weight off

Moreover, under stress conditions, MAPKs in plants can modulate various transcription factors such as bZIP, MYB, MYC, and WRKY 171

In this particular group of patients who are older, who are diabetics, I really would caution against the extended use of GLP-1s, she said